Issue 51, 2022, Issue in Progress
From the journal:

RSC Advances

Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites

Maorong Wang,ab   Ping Yao,b   Minpeng Gao,c   Jian Jind  and  Yerong Yu*ad  

* Corresponding authors

a Department of Endocrinology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China
E-mail: 1100312222@vip.jiangnan.edu.cn, yerongyu@scu.cn

b Department of Endocrinology, Affiliated Hospital of Hubei University for Nationalities, Enshi 445000, Hubei, China

c China Pharmaceutical University, Nanjing, Jiangsu, P. R. China

d Jiangnan University, Wuxi, Jiangsu, P. R. China

Abstract

Expression of Concern for ‘Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites’ by Maorong Wang et al., RSC Adv., 2020, 10, 8044–8053, https://doi.org/10.1039/C9RA10593J.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D2RA90118H
Article type
Expression of Concern
Submitted
15 Nov 2022
Accepted
15 Nov 2022
First published
22 Nov 2022
This article is Open Access
Creative Commons BY license

RSC Adv., 2022,12, 33348-33348

Permissions

Request permissions

Expression of Concern: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites

M. Wang, P. Yao, M. Gao, J. Jin and Y. Yu, RSC Adv., 2022, 12, 33348 DOI: 10.1039/D2RA90118H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements